Vesnik 106/2007; 88/2010, Skopje, 2007, 2010;Fond za zdravstveno osiguruvanje na Makedonija, Pravilnik za utvrduvanje nakriteriumite i postapka za odreduvanje na referentni tseni na lekovi, Sl.Vesnik 8/2008, 158/2009, Skopje, 2008, 2009;Angelovska B., Ivanovska V., Changes in the prices of medicines from the medicineslist reimbursed by the Health Insurance Fund in Republic of Macedonia after the im-plementation of reference pricing for medicine procurement, Fifth Congress of phar-macists of Serbia with international participation, Belgrade, 2010;Angelovska B., M.Bukilica, T. Todorov, G. Petrova. Comparative analysis of the pricesof essential medicines between Bulgaria and Macedonia. 4th Pharm. Congress withinternational participation, Sofija, 2005;Banks G. et all., International pharmaceutical price differences-research report, Mediaand Publications, Commonwealth of Australia, 2001;Lopez-Casasnova G, Puig-Junoy J. Review of the literature on reference pricingDepartment of Economics and Business Research Center for Health and Economics(CRES). Universitat Pompeu Fabra. Barcelona (Spain); 2000;Madrid Y,Quick J, Velasquez G. Health reform and drug financing World HealthOrganization; 1998 WHO/DAP/98.3;The guide to European pharmaceutical pricing and reimbursement system, Urchpubl. London, 2001;WHO/HAI, Measuring medicine prices, availability, affordability and price components,2nd edition, Geneva, 2008;www.moh-hsmp.gov.mk/Svetska banka, Proekt za upravuvanje so zdravstven sektorwww.fzo.org.mk /Fond za zdravstveno osiguruvanje na Makedonijawww.reglek.com.mk/ Biro za lekovi, Ministerstvo za zdravstvo na RepublikaMakedonijaPRODAzhNI I REFERENTNI TsENI NADVAESETTE NAJPOTROshUVANI lEKOVIOD POzITIVNATA lISTA NA lEKOVINA REPUblIKA MAKEDONIJAPO VOVEDUVAnjE NA SISTEMOTNA REFERENTNI TsENIBistra Angelovska1, Veritsa Ivanovska1,Slavitsa Maleska Stojadinovikj21UGD Fakultet za meditsinski nauki, 2JZU Opshta bolnitsa OkhridVOVEDVo Republika Makedonija nabavkata na lekovite od Listata na le-kovi koi pagjaat na tovar na Fondot za zdravstveno osiguruvanje naMakedonija (Pozitivna lista) do 2004 godina se vrsheshe tsentralnopreku organiziranje na megjunarodni tenderi. Glavniot kriterium zaizbor na najpovolna ponuda na tenderot beshe tsenata na lekovite,shto ja odreduvashe i tsenata na lekovite od Pozitivnata lista.Posledniot megjunaroden tender na lekovi se odrzha vo 2004 godinaso vazhnost do potroshuvanje na dogovorenite kolichini nabavenilekovi.Vo 2007 godina se donese prviot Pravilnik za utvrduvanje na kri-teriumite i postapkata za odreduvanje na referentnite tseni nalekovite od Pozitivnata lista, koj vo predvid ja zemashe najniskataponudena tsena na posledniot tender na lekovi. Vo 2009 godina sedonese vtoriot Pravilnik za referentni tseni koj koristi spored-bena analiza na tsenite vo referentnite zemji vo regionot. Refe-rentna tsena e maksimalniot iznos koj Fondot go obezbeduva zaodreden lek na retseptTsEl NA STUDIJATADa se utvrdi dali i kolku osigurenikot doplakja od referentnatado prodazhnata tsena za dvaesette najpotroshuvani lekovi od Pozi-tivnata lista na lekovi dostapni vo aptekite vo 2009 godina.METODIZa ovaa studija pravena e sporedbena statistichka analiza za opre-deluvanje na razlikite megju referentnata i prodazhnata tsena nadvaesette najpotroshuvani lekovi vo 2009 godina od Pozitivnatalista na lekovi.Tsenite na site registrirani preparati so isto INN i jachina seobjaveni vo Registerot na Ministerstvoto za zdravstvo za 2009godina.REzUlTATISo koristenje na Metodologijata na referentni tseni od 2009 god.za utvrduvanje na tsenite na lekovite od Pozitivnata lista, Fondotza zdravstveno osiguruvanje plakja poniski tseni na lekovite na li-stata, dodeka patsientite ja doplakjaat razlikata megju prodazhnatai referentnata tsena na lekovite.DISKUSIJAMetodologijata na referentni tseni ovozmozhuva namaluvanje natsenite na najpotroshuvanite lekovi preku zgolemena ponuda napazarot za lekovi so isto generichko ime. Toa najverojatno se dol-zhi na (1) grupiranje na lekovite po ATTs klasifikatsija i (2) spore-duvanje na tsenite na istata generika vo referentite zemji odregionot.Za sporedba, vo 2005 godina koga nabavkata na lekovi od Pozitiv-nata tsena odeshe preku tender, patsientot ne doplakjashe za lekovite.So ovaa metodologija, asortimanskata ponuda beshe limitirana naonie lekovi od Pozitivnata lista koi dobile na tenderot, a nivna-ta tsena beshe fiksno utvrdena.zAKlUChOKSo metodologijata na referentni tseni se zgolemuva asortimanotna lekovi i se zashteduva od sredstvata na Fondot za zdravstvenoosiguruvanje nameneti za lekovi. No toa se odrazuva na standardotna patsientite koi najchesto ja doplakjaat razlikata mekju referen-tnata i maloprodazhnata tsena na lekovite dostapni vo aptekite.107fifth congress of pharmacy of maceDonia with international participationMacedonian Pharmaceutical Bulletin 57 (suppl), 2011PHARMACOECONOMY / SOCIAL PHARMACY/ PHARMACOINFORMATICS poster presentationsKORISTENA lITERATURAAngelovska B. Ratsionalna lekarstvena upotreba, farmatsevtichna dostavka itsenoobrazuvane, kato elementi na natsionalnata lekarstvena strategiia v Repu-blika Makedoniia, avtoreferat dokt. disertatsiia, Sofija,2006;Petrova G. Model na reformata na farmatsevtichniia sektor v strani v prekhod otBalkanskiia region - analiz na ispolzvanite teoretichni kontseptsii, avtoreferatdokt. disertatsiia, Sofija, 2004;Sobranie na Republika Makedonija, Zakon za zdravstvenoto osiguruvanje, Sl.Vesnik 119/2005, 50/2010 Skopje, 2005, 2010;Sobranie na Republika Makedonija, Zakon za lekovite i meditsinskite pomagala,Sl. Vesnik 106/2007; 88/2010, Skopje, 2007, 2010;Fond za zdravstveno osiguruvanje na Makedonija, Pravilnik za utvrduvanje nakriteriumite i postapka za odreduvanje na referentni tseni na lekovi, Sl.Vesnik 8/2008, 158/2009, Skopje, 2008, 2009;Angelovska B., Ivanovska V., Changes in the prices of medicines from the medicineslist reimbursed by the Health Insurance Fund in Republic of Macedonia after the im-plementation of reference pricing for medicine procurement, Fifth Congress of phar-macists of Serbia with international participation, Belgrade, 2010;Angelovska B., M.Bukilica, T. Todorov, G. Petrova. Comparative analysis of the pricesof essential medicines between Bulgaria and Macedonia. 4th Pharm. Congress withinternational participation, Sofija, 2005;Banks G. et all., International pharmaceutical price differences-research report, Mediaand Publications, Commonwealth of Australia, 2001;Lopez-Casasnova G, Puig-Junoy J. Review of the literature on reference pricingDepartment of Economics and Business Research Center for Health and Economics(CRES). Universitat Pompeu Fabra. Barcelona (Spain); 2000;Madrid Y,Quick J, Velasquez G. Health reform and drug financing World HealthOrganization; 1998 WHO/DAP/98.3;The guide to European pharmaceutical pricing and reimbursement system, Urchpubl. London, 2001;WHO/HAI, Measuring medicine prices, availability, affordability and price components,2nd edition, Geneva, 2008;www.moh-hsmp.gov.mk/Svetska banka, Proekt za upravuvanje so zdravstven sektorwww.fzo.org.mk /Fond za zdravstveno osiguruvanje na Makedonijawww.reglek.com.mk/ Biro za lekovi, Ministerstvo za zdravstvo na RepublikaMakedonijaanalysis of the consumptionof magistral anD galenic meDicinesfrom 2001 to 2010 in the publicgeneral hospital ohriDSlavica Maleska Stojadinovik1, Bistra Angelovska2,Verica Ivanovska21Public General Hospital Ohrid,2UGD Stip, Faculty of Medicial SciencesThe production of medicines in pharmacies based on practical and scien-tific know-how has been a long tradition in the pharmacy practice. It givesthe opportunity to produce small batches of medicines as well as medi-cines for a single patient where industrial manufacture is not an option.The production of magistral and galenic medicines is performed in line withrespective regulations and under defined conditions, so that the patient isgiven a medicine of good quality according to determined standards.The production of medicines in a pharmacy/galenic laboratory is ahighly scientific activity, and it is undertaken in correspondence togood practices, the pharmacopeia directions and other scientific doc-uments. Thereby, the pharmacist makes judgments and takes deci-sions about the correct process and procedure in order to secure thequality of the produced medicines.During the period 2001 - 2005 the State pharmacy in Ohrid comprisedof a number of pharmacies and a galenic laboratory, where magistraland galenic medicines were prepared to meet the needs of its ownpharmacies.In 2005 the pharmacies were privatized according to the modificationsin the Law of Health Protection (Official Gazette 03/2004), and thegalenic laboratory became part of the hospital pharmacy within thePublic General Hospital in Ohrid.Despite all these changes, the galenic laboratory produces magistralmedicines for the pharmacies and galenic medicines for the hospitalsand other health institutions on a continuous basis.The objective of this study is to follow the consumption of magistralmedicines in the galenic laboratory in Ohrid from 2001 to 2010 basedon written prescriptions, composition, and dosage forms, and toanalyse the influence of the changes in the legislation and in the phar-macy market on the production volume.The conclusion of the study is that the modifications in the legisla-tion, the consumption of broader selection of finished medicines andthe competition of recently opened galenic laboratories have lead todecrease in the production of magistral medicines in the galenic lab-oratory in Ohrid.ANAlIzA NA POTROshUVAChKATANA MAGISTRAlNI I GAlENSKI lEKOVIVO PERIODOT OD 2001 DO 2010 GODINAVO JzU OPshTA bOlNITsA OkhRIDSlavitsa Maleska Stojadinovikj1,Bistra Angelovska2, Veritsa Ivanovska21JZU Opshta bolnitsa Okhrid,2UGD Shtip fakultet za meditsinski naukiIzrabotkata na lekovi vo Aptekite so primena na praktichnite inauchnite znaenja e dolgogodishna traditsija vo farmatsevtskata praksai pruzha mozhnost za priprema na mali serii na lekovi, kako i lekoviza poedinechen patsient, za koi ne e mozhno industrisko proizvodstvo.Izrabotkata na magistralni i galenski lekovi/preparati vo aptekase izveduva vo soglasnost so soodvetni propisi i definiraniuslovi, taka da patsientot dobiva lek so dobar kvalitet, sporedpropishanite standardi.Izrabotkata na lekovi vo apteka/galenska laboratorija e visokostruchna rabota na farmatsevtot i se vrshi soglasno dobrite praksi,propisite na farmakopeite ili drugi struchni dokumenti, pri shtofarmatsevtot protsenuva i nosi odluki za najispravnata postapka iprotsedurite shto obezbeduvaat kvalitet na izraboteniot preparat.Vo periodot od 2001 do 2005 godina Gradskata apteka vo Okhrid vosvojot sostav imashe povekje apteki i galenska laboratorija, vo kojase izrabotuvaa magistralni i galenski preparati za potrebite naaptekite vo sostav na ustanovata.2005 godina soglasno promenite vo Zakonot za zdravstvenatazashtita (Sl.